MARKET

VALN

VALN

Valneva Se
NASDAQ
6.55
+0.05
+0.77%
After Hours: 6.54 -0.01 -0.15% 16:00 07/18 EDT
OPEN
6.55
PREV CLOSE
6.50
HIGH
6.55
LOW
6.52
VOLUME
2.57K
TURNOVER
--
52 WEEK HIGH
8.66
52 WEEK LOW
3.620
MARKET CAP
531.85M
P/E (TTM)
-24.0809
1D
5D
1M
3M
1Y
5Y
1D
MP Materials, CoreWeave, Trade Desk And Other Big Stocks Moving Higher On Tuesday
Benzinga · 5d ago
Weekly Report: what happened at VALN last week (0707-0711)?
Weekly Report · 6d ago
Valneva’s Chikungunya Vaccine Restriction Lifted by EMA
TipRanks · 07/11 18:28
Valneva's Chikungunya Vaccine IXCHIQ Cleared By European Medicines Agency For Use In Seniors After Safety Committee Review
Benzinga · 07/11 15:36
European Medicines Agency Lifts Temporary Restriction on Valneva's Chikungunya Vaccine IXCHIQ® for Elderly After Safety Review
Reuters · 07/11 15:35
VALNEVA ANNOUNCES LIFTING OF EUROPEAN MEDICINES AGENCY’S TEMPORARY RESTRICTION ON USE OF CHIKUNGUNYA VACCINE IXCHIQ® IN ELDERLY
Reuters · 07/11 15:35
Valneva's chikungunya vaccine suspension gets lifted for older adults
Seeking Alpha · 07/11 13:51
BRIEF-EMA's PRAC Lifts Temporary Restriction On Ixchiq Vaccination For People 65 Years & Older
Reuters · 07/11 10:50
More
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Webull offers Valneva SE (ADR) stock information, including NASDAQ: VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.